“Description of the 3 Tranquillo Phase 3 clinical program study designs to assess ritlecitinib treatment in adults and adolescents with nonsegmental vitiligo”, J of Skin, vol. 9, no. 6, p. s714, Nov. 2025, doi: 10.25251/rm8etw25.